CAS 1373615-35-0

Fórmula: C20H25ClN4O3S

InChI: InChI=1S/C20H25ClN4O3S/c1-14-10-15(2)20(23-12-14)16-11-18(22-13-17(16)21)24-5-7-25(8-6-24)19(26)4-9-29(3,27)28/h10-13H,4-9H2,1-3H3

Clave InChI: BBVNTTZIOTWDSV-UHFFFAOYSA-N

SMILES: CC1=CC(=C(N=C1)C2=CC(=NC=C2Cl)N3CCN(CC3)C(=O)CCS(=O)(=O)C)C

1-(4-(5'-Chloro-3,5-Dimethyl-[2,4'-Bipyridin]-2'-Yl)Piperazin-1-Yl)-3-(Methylsulfonyl)Propan-1-One

CAS: 1373615-35-0

1-(4-(5'-Chloro-3,5-Dimethyl-[2,4'-Bipyridin]-2'-Yl)Piperazin-1-Yl)-3-(Methylsulfonyl)Propan-1-One

Fórmula: C₂₀H₂₅ClN₄O₃S

Pureza: 98%

Peso molecular: 436.96

Ref: 54-OR1023184

PF-5274857

CAS: 1373615-35-0

PF-5274857

Fórmula: C₂₀H₂₅ClN₄O₃S

Pureza: ≥98%

Peso molecular: 436.96

Ref: 54-BUP09898

PF-5274857

CAS: 1373615-35-0

1-(4-(5'-Chloro-3,5-dimethyl-[2,4'-bipyridin]-2'-yl)piperazin-1-yl)-3-(methylsulfonyl)propan-1-one

Fórmula: C₂₀H₂₅ClN₄O₃S

Pureza: 98%

Peso molecular: 436.96

Ref: IN-DG305572

PF-5274857

CAS: 1373615-35-0

PF-5274857: selective hedgehog pathway inhibitor (IC50: 5.8 nM, Ki: 4.6 nM), treats brain tumors, crosses blood-brain barrier, orally stable.

Fórmula: C₂₀H₂₅ClN₄O₃S

Pureza: 98.53%

Forma y color: White Solid

Peso molecular: 436.956

Ref: TM-T5465

PF 5274857

CAS: 1373615-35-0

Smoothened (SMO) receptor antagonist

Fórmula: C₂₀H₂₅ClN₄O₃S

Pureza: Min. 95%

Peso molecular: 436.96 g/mol

Ref: 3D-FP143186

PF-5274857

CAS: 1373615-35-0

Fórmula: C₂₀H₂₅ClN₄O₃S

Pureza: 98%

Forma y color: Solid

Peso molecular: 436.9555

Ref: IN-DA009CE6